UK must learn biotech lessons from the US
This article was originally published in Clinica
Executive Summary
The UK must learn from the development of the biotechnology sector in the US if it is to maintain its lead in Europe, according to a new report from the UK government. Measures are needed to support the science base, to encourage the flow of venture capital and to develop urban planning policies to allow clusters of expertise to grow, says the UK Department of Trade and Industry.
You may also be interested in...
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.